483 Mirgen Pharmaceutical Jan 2012

483 Mirgen Pharmaceutical Jan 2012

S. Brown FDA$119.00 - Available Now

FDA investigators audited the Mirgen Pharmaceutical - Boise, ID, United States facility and issued 9 inspectional observations (via FDA 483) on 30 Jan 2012.

Product details

  • Category: Human Drugs
  • Number of Observations: 9
  • Inspection end: 30 Jan 2012
  • Location: Boise, United States
  • FEI: 3009078612
Add To Cart